SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DEGLI UBERTI, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.972
EU - Europa 7.986
AS - Asia 5.291
SA - Sud America 164
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 15
OC - Oceania 7
Totale 37.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.904
CN - Cina 2.750
DE - Germania 2.541
UA - Ucraina 1.930
SG - Singapore 1.288
TR - Turchia 1.124
IT - Italia 991
GB - Regno Unito 694
FI - Finlandia 574
SE - Svezia 469
RU - Federazione Russa 346
PL - Polonia 155
BR - Brasile 140
FR - Francia 94
BE - Belgio 70
CA - Canada 56
NL - Olanda 34
IR - Iran 24
ID - Indonesia 20
IN - India 18
LT - Lituania 16
EU - Europa 14
IE - Irlanda 12
CZ - Repubblica Ceca 11
MA - Marocco 10
RO - Romania 10
VN - Vietnam 10
JP - Giappone 9
BD - Bangladesh 7
HK - Hong Kong 7
CH - Svizzera 6
MX - Messico 6
AT - Austria 5
AU - Australia 5
DK - Danimarca 5
EC - Ecuador 5
MY - Malesia 5
PK - Pakistan 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
ES - Italia 4
IQ - Iraq 4
PE - Perù 4
PT - Portogallo 4
CY - Cipro 3
HU - Ungheria 3
PY - Paraguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BG - Bulgaria 2
CL - Cile 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
MC - Monaco 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 37.453
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.027
Fairfield 2.448
Jacksonville 2.158
Chandler 2.078
Ashburn 1.738
Houston 1.721
Santa Clara 1.316
Ann Arbor 1.271
Wilmington 950
Singapore 948
Seattle 939
Cambridge 747
Izmir 676
Nanjing 616
Beijing 546
Princeton 439
Addison 384
San Diego 275
Boardman 267
Milan 209
Shenyang 198
Shanghai 192
Nanchang 180
Helsinki 175
New York 165
Dearborn 163
Warsaw 154
Ferrara 135
Hebei 134
Los Angeles 123
Changsha 112
Bremen 109
Tianjin 107
Washington 107
Jiaxing 97
Jinan 83
Falls Church 69
Mountain View 67
Brussels 64
San Mateo 62
London 55
Kunming 47
Norwalk 47
Zhengzhou 46
Ningbo 45
Redwood City 44
Guangzhou 43
Carrara 40
Munich 39
Auburn Hills 36
Tappahannock 36
Taizhou 34
Leawood 30
Frankfurt am Main 29
Toronto 29
Orange 28
Düsseldorf 27
Des Moines 26
Falkenstein 25
Indiana 25
Hefei 24
Augusta 22
Hangzhou 21
Jakarta 20
Verona 20
Monmouth Junction 18
Ardabil 17
Philadelphia 17
Bologna 16
Lanzhou 15
Ottawa 14
Rome 14
Changchun 13
Ferrara di Monte Baldo 12
Haikou 11
Padova 10
Redmond 10
Chengdu 9
Dong Ket 9
Belo Horizonte 8
Chicago 8
Kilburn 8
Mumbai 8
San Francisco 8
Walnut 8
Yellow Springs 8
Fuzhou 7
Hounslow 7
Prescot 7
Dallas 6
Dublin 6
Hong Kong 6
Livorno 6
Naples 6
São Paulo 6
Tangier 6
Castelnuovo Rangone 5
Olomouc 5
Stockholm 5
Brescia 4
Totale 26.410
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 342
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 242
Igf-I influences everolimus activity in medullary thyroid carcinoma 171
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 169
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 165
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 165
Circadian profile of plasma calcitonin gene-related peptide in healthy man 163
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 163
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 162
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 160
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 156
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 152
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 151
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 150
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 146
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 145
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 145
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 144
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 143
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 143
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 141
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 140
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 136
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 136
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 136
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 135
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 135
Characterization of a deleted Y chromosome in a male with Turner stigmata 135
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 133
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 132
Functional characterization of a new deletion in CDKN1B 5'-UTR region 131
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 131
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 130
null 130
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 129
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 129
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 129
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 129
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 128
Pituitary side effects of old and new drugs. 127
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 127
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 127
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 127
Cerebral aneurysm and acromegaly: a case report 126
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 126
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 126
Atrial strain is the main determinant of release of atrial natriuretic peptide 125
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 125
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 125
Role of the serotonergic system in the genesis of vasovagal syncope. 124
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 124
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 124
Post-partum thyroiditis - A clinical update 123
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 123
Dermorphin inhibits spinal nociceptive flexion reflex in humans 123
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 123
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 122
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 122
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 122
In vitro testing of new somatostatin analogs on pituitary tumor cells 121
Iodine excess and hyperthyroidism 121
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 121
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 121
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 121
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 120
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 120
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 120
Rare diseases in clinical endocrinology: a taxonomic classification system. 120
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 120
L’iperplasia surrenale congenita e la pubertà precoce 119
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 119
Changes of plasma calcitonin gene-related peptide levels in postmenopausal women 119
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 119
null 118
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 118
Growth hormone excess promotes breast cancer chemoresistance 118
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 117
Growth hormone and skeletal muscle function 117
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 117
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 116
Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia 115
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 115
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 115
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 115
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 115
null 114
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 114
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 114
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 114
miR-15a and miR-16-1 down-regulation in pituitary adenomas 114
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 114
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 113
null 113
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 113
Evidence for androgen receptor gene expression in human thyroid cells and tumours 113
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 113
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 113
A C-MYC GENE VARIANT WITHOUT EXON 1 AND WITH AN ABNORMAL METHYLATION PATTERN INHERITED IN A WOMAN WITH NO EVIDENCE OF MAMLIGNANCY 112
null 111
null 111
Totale 13.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.301
Totale 185.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.481 0 0 0 0 0 0 0 715 447 827 395 97
2020/20214.416 463 380 205 586 164 495 115 520 68 522 688 210
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20253.495 230 180 625 210 1.067 876 307 0 0 0 0 0
Totale 37.764